Vaccines
4 September 2020
Johnson & Johnson Announces that Janssen’s COVID-19 Investigational Vaccine Candidate Prevents Severe Clinical Disease in Pre-clinical Studies3 September 2020
Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate1 September 2020
Elixirgen Therapeutics planning to begin Phase I/II Clinical Trials of its COVID-19 Vaccine Candidate EXG-5003 at Fujita Health University1 September 2020
HDT BIO Receives NIH Contract to Advance Novel RNA/LION™ COVID-19 Vaccine Into Clinical Trials1 September 2020
Aegis Life, Inc. Launches to Fight COVID-19 via DNA Vaccines and Therapeutics Enabled by Proprietary Fusogenix Delivery Technology1 September 2020
Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups31 August 2020
Daiichi Sankyo Selected for AMED’s “Development of a Vaccine for COVID-19 Vaccines (Second Round)”28 August 2020
Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results27 August 2020
GSK announces first participant vaccinated in phase 3 clinical trials of its 5-in-1, meningitis ABCWY vaccine candidate25 August 2020
Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Smallpox Vaccine25 August 2020
Intravacc and Therapyx jointly develop the world’s first prophylactic gonorrhea vaccine24 August 2020
ReiThera’s COVID-19 Vaccine Candidate Enters Phase 1 Clinical Study with First Healthy Volunteer Dosed in Italy21 August 2020
Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-1919 August 2020
ERC Announces Interim Results from Phase 2 Trial of Immunotherapy ERC1671 in Recurrent Glioblastoma Patients17 August 2020
OSE Immunotherapeutics Publishes Positive Preclinical COVID-19 Vaccine Results With Multi-Target Vaccine CoVepiT13 August 2020
Heat Biologic’s COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies10 August 2020
Vaxart Announces IND Filed for COVID-19 VaccineNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports